Articles by Louis Garguilo

  1. View From Tokyo: Rise Of The “Values” Chain 5/15/2020

    The Wuhan coronavirus outbreak has brokered a virulent "value" chain debate around the world, including a global CDMO's CEO situated in Tokyo. 

  2. A COVID-19 Vaccine, Outsourcing, And Made In The USA 4/27/2020

    That’s an unwieldy title for an editorial. But we’ll bundle those three components quickly, thanks to U.S.-based GeoVax Labs CEO David Dodd. He's the quintessential professional to assist readers in assessing and contemplating current and future realities.

  3. Pfizer Acquires Hospira: Biosimilars Gain Full Pharma Acceptance 2/5/2015

    Just days after Outsourced Pharma’s in-depth, two-part article on Hospira and the role of biosimilars in global healthcare, and in which I asked Hospira’s Sumant Ramachandra whether he foresaw a future where a Pfizer comes to Hospira to work together on biosimilars, we have a definitive answer.

  4. Biosimilars Part 2: It's All About Dollars Now 2/2/2015

    Time to table the discussion on the science of replicating biologics. It’s all about dollars now. Part two of our look at biosimilars in the U.S.

  5. Biosimilars: A Brief Manifesto of Morality And Markets 1/26/2015

    As best I can describe it, here's an ideology for biosimilars in the U.S. healthcare system, from Sumant Ramachandra, executive and scientist at Hospira, Inc.

  6. A Global Forum For Outsourcing (With Simple Objectives) 9/24/2014

    Perhaps the best advice I’ve heard regarding industry conferences is twofold: first, make sure you attend, and second, keep your objectives for attending simple.

  7. Serial Entrepreneur Points To Initial Funding Sources For Biotechs 9/24/2014

    Kevin Judice lists himself on LinkedIn as “Entrepreneur.” Perhaps he has to; there just isn’t enough space to include the three companies he recently started and at which he concurrently is employed as CEO or CSO.